IMCC - IM Cannabis Corp.

0.75
0.060   8.000%

Share volume: 82,913
Last Updated: 03-06-2026
Pharmaceutical Products/Medicinal Chemicals: 2.29%

PREVIOUS CLOSE
CHG
CHG%
$0.69
0.06
0.09%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Performance
5 Days
3.96%
1 Month
-34.21%
3 Months
-51.61%
6 Months
-59.46%
1 Year
-60.94%
2 Year
-64.11%
Key data
Stock price
$0.75
P/E Ratio 
N/A
DAY RANGE
$0.68 - $0.77
EPS 
N/A
52 WEEK RANGE
$0.65 - $7.12
52 WEEK CHANGE
-$58.79
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$34,742
AVERAGE 30 VOLUME 
$52,419
Company detail
CEO: Oren Shuster
Region: US
Website: imcannabis.com
Employees: 340
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

IM Cannabis Corp. engages in breeding, growing, and supply medical cannabis products. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers.

Recent news